Phase II Study of Ramucirumab and Docetaxel for NSCLC Patients with Malignant Pleural Effusion

S. Takemoto, M. Fukuda,H. Senju,K. Nakatomi, N. Sugasaki, R. Ogata, H. Tomono,T. Suyama,M. Shimada, K. Akagi, F. Hayashi,H. Gyotoku,H. Yamaguchi,S. Nagashima,H. Soda, A. Kinoshita,H. Mukae

JOURNAL OF THORACIC ONCOLOGY(2022)

引用 0|浏览8
暂无评分
关键词
Non-small cell lung cancer, malignant pleural effusion, ramucirumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要